Published in Healthcare Finance, Tax and Law Weekly, June 10th, 2009
George Evans, CEO stated: “This is a very exciting time for Cellceutix. The compounds covered by this patent application are structurally very...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.